Part D Medication Therapy Management Programs
Beginning with plan years that begin on or after 2 years after enactment, Part D prescription drug plan sponsors would be required to offer MTM services to targeted beneficiaries, including an annual comprehensive review of medications (either in person or through telehealth technologies as defined by the Secretary) by a licensed pharmacist or other qualified provider, which may result in an action plan; a written summary of the review in a standardized format; and follow-up interventions as warranted based on the findings of the review (which may be provided person-to-person or using telehealth technologies as defined by the Secretary). Sponsors would be required to assess on at least a quarterly basis the medication use of individuals who are at risk but not enrolled in the MTM program. Plans must also enroll beneficiaries who qualify on a quarterly basis and allow for opt out. (Sec. 10328)
Navigation: ( ←Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | Next→ )